These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 22275836
1. RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin. Xu J, Zhao JH, Liu Y, Feng NP, Zhang YT. Int J Nanomedicine; 2012; 7():211-9. PubMed ID: 22275836 [Abstract] [Full Text] [Related]
2. Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo. Xing J, Zhang D, Tan T. Int J Biol Macromol; 2007 Jan 30; 40(2):153-8. PubMed ID: 16901536 [Abstract] [Full Text] [Related]
3. RGD-conjugated PLA-PLL nanoparticles targeting to Bacp-37 breast cancer xenografts in vivo. Liu P, Qi X, Sun Y, Wang H, Li Y, Duan Y. J Nanosci Nanotechnol; 2011 Dec 30; 11(12):10760-4. PubMed ID: 22408990 [Abstract] [Full Text] [Related]
5. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Jia L, Shen J, Zhang D, Duan C, Liu G, Zheng D, Tian X, Liu Y, Zhang Q. Int J Biol Macromol; 2012 Apr 01; 50(3):523-9. PubMed ID: 22301003 [Abstract] [Full Text] [Related]
7. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin. Zheng D, Duan C, Zhang D, Jia L, Liu G, Liu Y, Wang F, Li C, Guo H, Zhang Q. Int J Pharm; 2012 Oct 15; 436(1-2):379-86. PubMed ID: 22732673 [Abstract] [Full Text] [Related]
9. The design and synthesis of redox-responsive oridonin polymeric prodrug micelle formulation for effective gastric cancer therapy. Xu L, Zhu L, Zheng K, Liu J, Tian P, Hu D, Wang Q, Zuo Q, Ouyang X, Dai Y, Fu Y, Dai X, Huang F, Cheng J. J Mater Chem B; 2021 Apr 07; 9(13):3068-3078. PubMed ID: 33885668 [Abstract] [Full Text] [Related]
10. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery. Zhao Y, Lin D, Wu F, Guo L, He G, Ouyang L, Song X, Huang W, Li X. Int J Mol Sci; 2014 Sep 29; 15(10):17565-76. PubMed ID: 25268623 [Abstract] [Full Text] [Related]
11. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Liu M, Li H, Luo G, Liu Q, Wang Y. Arch Pharm Res; 2008 Apr 29; 31(4):547-54. PubMed ID: 18449515 [Abstract] [Full Text] [Related]
12. Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin. Sun H, Nai J, Deng B, Zheng Z, Chen X, Zhang C, Sheng H, Zhu L. Molecules; 2024 Feb 05; 29(3):. PubMed ID: 38338476 [Abstract] [Full Text] [Related]
13. Biodegradable self-assembled MPEG-PCL micelles for hydrophobic oridonin delivery in vitro. Xue B, Wang Y, Tang X, Xie P, Wang Y, Luo F, Wu C, Qian Z. J Biomed Nanotechnol; 2012 Feb 05; 8(1):80-9. PubMed ID: 22515096 [Abstract] [Full Text] [Related]
17. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats. Zhang X, Liu L, Chai G, Zhang X, Li F. Drug Dev Ind Pharm; 2013 Nov 15; 39(11):1618-24. PubMed ID: 24087853 [Abstract] [Full Text] [Related]
20. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer. Liu Y, Feng L, Liu T, Zhang L, Yao Y, Yu D, Wang L, Zhang N. Nanoscale; 2014 Mar 21; 6(6):3231-42. PubMed ID: 24500240 [Abstract] [Full Text] [Related] Page: [Next] [New Search]